Newsfeeds - Spark Newswire

1 minute read

Regeneron-Sanofi’s Dupixent Wins European Approval For Prurigo Nodularis

Today, 3:13 AM

The European Commission (EC) has expanded the marketing authorization of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) for moderate-to-severe prurigo…

REGN

1 minute read

Kymera Therapeutics Stock Jumps After Positive Data From Atopic Dermatitis Trial

By Vandana Singh

Today, 3:13 AM

Kymera Therapeutics Inc (NASDAQ:KYMR) announced clinical results from the patient cohort portion of its KT-474 (IRAK4) Phase 1 trial in hidradenitis…

KYMR

1 minute read

M&A
News

Sanofi Shares Up 1% Premarket; Co on Sunday Announced it Will Not Bid for Horizon Therapeutics

By Charles Gross

Today, 3:13 AM

Sanofi S.A. ("Sanofi") regularly evaluates a wide variety of business development opportunities and this has included the evaluation of a possible transaction involving Horizon. As transaction price expectations do not meet our value creation criteria, Sanofi announces it is no longer in discussions with Horizon and it does not intend to make an offer for Horizon.

HZNP

1 minute read

Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration

By Vandana Singh

Today, 3:13 AM

Revolution Medicines Inc (NASDAQ:RVMD) announced that Sanofi SA (NASDAQ:SNY) has terminated global SHP2 development and commercialization collaboration. Following termination, Revolution Medicines will…

AMGN

1 minute read

Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac

By Vandana Singh

Today, 3:13 AM

U.S. District Judge Robin Rosenberg in Florida has dismissed about 50,000 claims associated with GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE), Sanofi SA (NASDAQ:SNY), and Boehringer Ingelheim, claiming…

GSK

1 minute read

Why GSK Plc And Sanofi SA Stock Are Shooting Higher

By Henry Khederian

Today, 3:13 AM

Shares of GSK plc (NYSE: GSK) and Sanofi SA (NASDAQ: SNY) are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit.

GSK

1 minute read

GSK, Pfizer, Sanofi, Boehringer Ingelheim Defeat Thousands Of U.S. Lawsuits Over Zantac Cancer Claims; Cases In Federal Court Will End While Others Continue In State Courts

By Benzinga Newsdesk

Today, 3:13 AM

- Court Order

GSK

1 minute read

Hearing GlaxoSmithKline And Sanofi Wins In A Zantac Product Liability Lawsuit; The Companies Were Granted Summary Judgement By The Court; Shares Move Higher

By Benzinga Newsdesk

Today, 3:13 AM

"As a result, if the plaintiff does not have this evidence, there is no genuine dispute of material fact, and the defendant is entitled to judgement as a matter of law," according to the judge's

GSK

1 minute read

If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash

By Anusuya Lahiri

Today, 3:13 AM

Sanofi (NASDAQ:SNY) said that if it ever bid for biotech company Horizon Therapeutics Public Limited Co (NASDAQ:HZNP), it would do so in…

AMGN

1 minute read

M&A
News

Sanofi Confirmed That Any Offer for Horizon Therapeutics if Made by Sanofi, Will Be Cash

By Charles Gross

Today, 3:13 AM

As required by Rule 2.12 of the Takeover Rules, Sanofi S.A. ("Sanofi") confirms that any offer for Horizon Therapeutics plc, if made by Sanofi, will be solely in cash. There is no certainty that any offer will be made, nor as to the terms on which any such offer may be made, if forthcoming.

HZNP